Explore our corporate updates and press releases below. For the latest news, follow us on LinkedIn.
To learn more about our company, visit our Corporate Overview page. To see our progress toward new answers and disease-centric therapies, visit our Pipeline page or review recent articles and studies on our Publications page.
|05/12/2022||Pharma Boardroom: Cyril Konto, President & CEO – Ichnos Sciences||Media|
|04/27/2022||Law360: Ichnos Sciences’ New GC On Carving Out ‘Creative Time’||Media|
|04/12/2022||Genetic Engineering & Biotechnology News: Multi-Specific Ab Analytical Strategies||Media|
|12/16/2021||Scrip: Ichnos Gets Going With Almirall Deal, Multiple Myeloma Bispecifics Add Sheen||Media|
The link above is provided for your convenience, and Ichnos is not responsible for content, privacy, or security issues associated with your visit to external websites.